Get 10 Free Leads on us
Use our Chrome Extension & instantly connect with prospects
IN8bio
IN8bio was founded with the mission of developing next-generation cellular therapies for treating cancer. The Company is developing allogeneic, autologous and genetically modified gamma-delta T cell therapies. The company was founded in 2016 and is located in New York, New York.
In8bio Inc
IN8bio
Headquarters
$7.2 M
34
2016
IN8bio raised a total of $150 K in funding over 1 rounds, and is a public traded company.
NASDAQ: INAB
Here's a list of some of the top trending technologies and APIs used by IN8bio.
(3 Technologies)
(2 Technologies)
(2 Technologies)
(2 Technologies)
(2 Technologies)
Company | Employees | Revenue | Top technologies |
---|---|---|---|
Tactiva Therapeutics | 15 | $4.9 M | |
HighPassBio | 20 | $4 M | |
Aurora BioPharma | 25 | $5.1 M | |
PhotonPharma | 5 | $834 K | |
Immunova Therapeutics | 6 | $1.3 M |